Literature DB >> 1481472

Transfusion management of patients with IgA deficiency and anti-IgA during liver transplantation.

R D Davenport1, K L Burnie, R M Barr.   

Abstract

Severe anaphylactic or allergic reactions may occur during blood transfusion to patients who are IgA-deficient and have anti-IgA in their blood, particularly those with class-specific antibodies. These patients are a particular challenge to the hospital transfusion service when large volumes of blood components are required for transfusion support, as in liver transplantation. We have successfully provided blood components for 3 such patients undergoing liver transplantation. Red cells were washed manually or by automated technique. Platelets were washed manually. All plasma was from IgA-deficient donors. One patient's entire plasma requirements were supplied by autologous plasmapheresis. Serial determinations of IgA levels and anti-IgA titers in 1 patient demonstrated an abrupt fall in anti-IgA with the appearance of barely detectable amounts of IgA during the surgery. IgA-containing plasma cells were demonstrated in the biopsies of liver homografts of 2 patients following transplantation. IgA deficiency with anti-IgA can be successfully managed during liver transplantation with advance planning.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1481472     DOI: 10.1111/j.1423-0410.1992.tb01229.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  3 in total

1.  Long-Term Treatment and Transfusion of Normal Blood Components Following Tolerance Induction in Patients with Anti-IgA Anaphylactic Reactions.

Authors:  Abdulgabar Salama; Romina Kardashi; Olga Arbach
Journal:  Transfus Med Hemother       Date:  2014-09-15       Impact factor: 3.747

2.  Immune tolerance induction in patients with IgA anaphylactoid reactions following long-term intravenous IgG treatment.

Authors:  N Ahrens; C Höflich; S Bombard; H Lochs; H Kiesewetter; A Salama
Journal:  Clin Exp Immunol       Date:  2008-03       Impact factor: 4.330

3.  Recommendations on Selection and Processing of RBC Components for Pediatric Patients From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Nicole D Zantek; Robert I Parker; Leo M van de Watering; Cassandra D Josephson; Scot T Bateman; Stacey L Valentine; Meghan Delaney
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.